Literature DB >> 2412393

Hyalinoid giant cell gastritis. A unique gastric lesion associated with eosinophilic hyalinoid degeneration of smooth muscle.

M Hanada, M Takami, K Hirata, T Nakajima.   

Abstract

A rare case of degenerative and inflammatory lesion of the stomach occurring in a 34-year-old woman is reported. Clinically, the lesion simulated gastric carcinoma because of the extensive involvement of the mucosa and submucosa by the process. Histologically, it was characterized by eosinophilic hyalinoid degeneration of smooth muscles in the muscularis mucosae as well as mucosal and submucosal blood vessels accompanied with foreign body giant cells and other inflammatory cells. The lesion occurred in association with chronic peptic ulcers, and a small submucosal nodule histologically compatible with inflammatory fibroid polyp coexisted within the area of this lesion. The patient has had no systemic disease and has been well for 4.5 years postoperatively. These clinical features suggest a localized nature of the lesion limited to the stomach. The term "hyalinoid giant cell gastritis" is proposed to describe this distinctive form of gastritis.

Entities:  

Mesh:

Year:  1985        PMID: 2412393

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  2 in total

1.  Xanthogranulomatous gastritis: association with xanthogranulomatous cholecystitis.

Authors:  M Guarino; D Reale; G Micoli; P Tricomi; E Cristofori
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

2.  Inflammatory Fibroid Polyp of the Gastrointestinal Tract: A Systematic Review for a Benign Tumor.

Authors:  Nikolaos Garmpis; Christos Damaskos; Anna Garmpi; Vasiliki E Georgakopoulou; Stratigoula Sakellariou; Aliki Liakea; Dimitrios Schizas; Evangelos Diamantis; Paraskevi Farmaki; Errika Voutyritsa; Athanasios Syllaios; Alexandros Patsouras; Georgia Sypsa; Alexandra Agorogianni; Athanasia Stelianidi; Efstathios A Antoniou; Konstantinos Kontzoglou; Nikolaos Trakas; Dimitrios Dimitroulis
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.